A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Clinical trial NCT02066415 · COMPLETED

Trial details

NCT number: NCT02066415
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Treatment for Prevention of Chronic Migraine

Start date: 2014-03-05
Primary completion: 2016-02-24
Enrollment: 667

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.